Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health field, with key products including various types of sleep breathing machines and monitoring devices [2] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across multiple countries [2] Financial Performance - For the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] Market Position - As of August 12, the company's stock closed at 97.77 yuan, up 6.63%, with a rolling price-to-earnings (PE) ratio of 49.38, marking a new low in 341 days, and a total market capitalization of 8.76 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 57.51, with a median of 41.25, placing Ruimait at the 84th position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders for Ruimait reached 9,118, an increase of 1,481 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]

Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [1] - The company holds a total of 633 domestic patents, including 107 invention patents and 390 utility model patents, as well as 202 international patents across multiple countries [1] Financial Performance - For Q1 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year [2] - The company's gross profit margin stands at 49.57% [2] Market Position - As of July 4, the company's stock closed at 83.14 yuan, with a rolling price-to-earnings (PE) ratio of 41.99, while the average PE ratio in the medical device industry is 51.05 [1][2] - The company's total market capitalization is 7.449 billion yuan [1] Capital Flow - On July 4, the company experienced a net outflow of 3.0578 million yuan in principal funds, with a total outflow of 370,800 yuan over the past five days [1]

Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [2] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across multiple countries [2] Financial Performance - For the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] Market Position - As of June 9, the company's stock closed at 84.6 yuan, down 1.12%, with a rolling price-to-earnings (PE) ratio of 42.73 times, and a total market capitalization of 7.58 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 50.64 times and a median of 37.05 times, Ruimait ranks 85th in terms of PE ratio [1][3] Shareholding Structure - As of the first quarter of 2025, a total of 14 institutions held shares in Ruimait, including 6 funds, 5 other institutions, 2 brokerages, and 1 social security fund, with a total holding of 26.92 million shares valued at 2.172 billion yuan [1]